NeurologyLive® Friday 5 — March 10, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Top Interviews from 2023 ACTRIMS: Expert Insights on Multiple Sclerosis

To recap the 2023 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, February 23-25, in San Diego, California, NeurologyLive® compiled a number of interviews with experts in the care of patients with multiple sclerosis—Marisa McGinley, DO; Farrah Mateen, MD, PhD; Laura Piccio, MD, PhD; Robert Zivadinov, MD, PhD; and Bruce Cree, MD, PhD, MAS, FAAN— as they shared their perspectives on hot topics of treatment and management from the forum.

2: Perspectives on Recent Advances in Alzheimer Disease

From our print issue, a panel of experts in dementia discussed the latest progress in the treatment of Alzheimer disease, and the various therapies that have progressed through the pipeline. The NeurologyLive® series panel features Marwan Sabbagh, MD; Alireza Atri, MD, PhD; Sharon Cohen, MD, FRCPC; and Eric McDade, DO.

3: NeuroVoices: Michael Dwyer, PhD, on Appropriately Incorporating Artificial Intelligence, ChatGPT into Multiple Sclerosis Care

In the latest edition of our in-depth Q&A series, the director of IT and Neuroinformatics Development at the Buffalo Neuroimaging Analysis Center sat down with NeurologyLive® to discuss some of the recent successes with AI, and how the field is quickly adapting to it. He also provided insight on how these approaches can be beneficial in the diagnosis, treatment, and management of MS going forward.

4: Biomarkers in MS

In episode 1 of the series Future Leaders in Neurology, Stephen Yeung, DO, provides an overview of biomarkers as related to multiple sclerosis, specifically the potential use of biomarkers for diagnostic purposes, prognostication, and measuring treatment response.

5: Reasons for the Increase in Parkinson Disease Incidence: James Beck, PhD

The senior vice president and chief scientific officer of the Parkinson’s Foundation sat down with NeurologyLive® in an interview to learn more about the underlying reasons driving PD incidence. He spoke about the rising age of society, how outdated previous estimates were, and why things like lifestyle choices, smoking, and environmental factors could play a role into these rates. [WATCH TIME: 5 minutes]